Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007362

Director acquired 290,498 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PAPPAJOHN JOHN Director 2016-09-21 Option exercise +290,498 $5.00 $1,452,490 353,357 D
Derivatives
PAPPAJOHN JOHN Director 2016-09-21 Option exercise · 5% Secured Convertible Note due December 2017 −0 D
PAPPAJOHN JOHN Director 2016-09-21 Returned to the company · Common Stock Warrant −0 0 D
Loading xslF345X03/s104194_form4.xml…